A Randomized, One-Year Clinical Trial Comparing the Efficacy of Topiramate, Flunarizine, and a Combination of Flunarizine and Topiramate in Migraine Prophylaxis

Pain Medicine

Volumn 13, Issue 1, 2012, Pages 80-86

  Luo, Ning ^a   Di, Wei ^a   Zhang, Aiwu ^a   Wang, Ying ^a   Ding, Minghui ^a   Qi, Weiwei ^b   Zhu, Yingting ^b   Massing, Mark W ^c   Fang, Yannan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c Carolinas Center for Medical Excellence   (United States)

Author keywords

Combination therapy; Flunarizine; Migraine; Prophylaxis; Topiramate

Indexed keywords

ACETYLSALICYLIC ACID; ERGOT ALKALOID; FLUNARIZINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; TOPIRAMATE; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GAIT DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MONOTHERAPY; PARESTHESIA; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RASH; TREATMENT OUTCOME;

EID: 84862933201     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01295.x     Document Type: Article

References (25)

1. Anderson KE, Vinge E. Beta-blockers and calcium channel blockers in the prophylaxis and treatment of migraine. Drugs 1990;39:355-73.
2. Hering R, Kuritzky A. Sodium valproate in the prophylactic treatment of migraine: A double blind placebo controlled study. Cephalalgia 1992;12:81-4.
3. Silberstein SD, Ashraf T, Chmie JJ, etal. Reduction in resource utilization associated with migraine preventive medication added to a "triptan" alone management strategy [abstrace]. Neurology 2000;54(suppl 3):A267.
4. Togha M, Ashrafian H, Tajik P. Open-label trial of cinnarizine in migraine prophylaxis. Headache 2006;46:498-502.
5. Silberstein SD. Migraine. Lancet 2004;363:381-91.
6. Silberstein SD, Goadsby PJ. Migraine: Preventive treatment. Cephalalgia 2002;22:491-512.
7. Ducros A, Denier C, Joutel A, etal. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 2001;345:17-24.
8. Silvestrini M, Bartolini M, Coccia M, etal. Topiramate in the treatment of chronic migraine. Cephalalgia 2003;23:820-4.
9. Silberstein SD, Neto W, Schmitt J, etal. Topiramate in migraine prevention: Results of a large controlled trial. Arch Neurol 2004;61:490-5.
10. Brandes JL, Saper JR, Diamond M, etal. Topiramate for migraine prevention: A randomized controlled trial. JAMA 2004;291:965-73.
11. Diener H, Matias-Guiu J, Hartung E, etal. Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: A comparison with propranolol 160mg daily. Cephalalgia 2002;22:209-21.
12. Freitag FG, Collins SD, Carlson HA, etal. A randomized trial of divalproex sodiumextended-release tablets in migraine prevention. Neurology 2002;58:1652-9.
13. Dodick DW. Acute and prophylactic management of migraine. Clin Cornerstone 2001;4:36-52.
14. Krymchantowski AV, Bigal ME. Polytherapy in the preventive and acute treatment of migraine: Fundamentals for changing the approach. Expert Rev Neurother 2006;6(3):283-9.
15. Pascual J, Leira R, Lainez JM. Combined therapy for migraine prevention? Clinical experience with a β-blocker plus sodium valproate in 52 resistant migraine patients. Cephalalgia 2003;23:961-2.
16. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24(suppl 1):9-160.
17. Pascual J, Lainez MJA, Leira R. Bending the rule of monotherapy for migraine prevention? Headache 2005;45:748-50.
18. Diener H, Tfelt-Hansen P, Dahlof C, etal. Topiramate in migraine prophylaxis: Results from a placebo-controlled trial with propranolol as an active control. J Neurol 2004;251:943-50.
19. Ashtari F, Shaygannejad V, Akbari M. A double-blind, randomized trial of low-dose topiramate vs propanolol in migraine prophylaxis. Acta Neurol Scand 2008;118:301-5.
20. Shaygannejad V, Janghorbani M, Ghorbani A, etal. Comparison of the effect of topiramate and sodium valproate in migraine prevention: A randomized blinded crossover study. Headache 2006;46:642-8.
21. Lo YL, Lum SY, Fook-Chong S, etal. A pilot study of topiramate dosages for migraine prophylaxis in an Asian population. J Headache Pain 2010;11:175-8.
22. Ho LL, Patrick K, Howan L, etal. Topiramate for migraine prophylaxis among Chinese population. Headache 2007;47:616-9.
23. Edwards CL, Fillingimc RB, Keefe F. Race, ethnicity and pain. Pain 2001;94:133-137.
24. Diener HC, Agosti R, Allais G, etal. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): A randomised, double-blind, placebo-controlled trial. Lancet Neurol 2007;6:1054-62.
25. Couch JR Jr. Placebo effect and clinical trials in migraine therapy. Neuroepidemiology 1987;6:178-85.